US Stock MarketDetailed Quotes
KRRO Korro Bio
- 47.360
- -1.020-2.11%
Close Jul 23 16:00 ET
- 47.360
- 0.0000.00%
Post 16:02 ET
439.17MMarket Cap-4677P/E (TTM)
49.300High46.900Low29.25KVolume48.430Open48.380Pre Close1.40MTurnover0.74%Turnover RatioLossP/E (Static)9.27MShares97.91052wk High2.90P/B186.41MFloat Cap9.15052wk Low--Dividend TTM3.94MShs Float2918.500Historical High--Div YieldTTM4.96%Amplitude9.150Historical Low47.827Avg Price1Lot Size
Korro Bio Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||
| Gross profit | ||||||
| Operating expense | 6.81%21.45M | 43.28%84.53M | 18.41M | 20.09M | 66.22%59M | 35.49M |
| Selling and administrative expenses | 46.16%7.88M | 62.43%27.28M | --5.28M | --5.39M | 43.70%16.8M | --11.69M |
| -General and administrative expense | 46.16%7.88M | 62.43%27.28M | --5.28M | --5.39M | 43.70%16.8M | --11.69M |
| Research and development costs | -7.64%13.57M | 35.66%57.25M | --13.13M | --14.69M | 77.28%42.2M | --23.81M |
| Operating profit | -6.81%-21.45M | -43.28%-84.53M | -18.41M | -20.09M | -66.22%-59M | -35.49M |
| Net non-operating interest income expense | ||||||
| Other net income (expense) | 297.71%1.91M | 247.23%3.39M | -385K | 481K | -92.79%976K | 13.54M |
| Other non- operating income (expenses) | 297.71%1.91M | 247.23%3.39M | ---385K | --481K | -92.79%976K | --13.54M |
| Income before tax | 0.33%-19.54M | -39.85%-81.15M | -17.65M | -19.61M | -164.25%-58.02M | -21.96M |
| Income tax | 17K | 170.00%27K | 0 | 400.00%10K | 2K | |
| Net income | 0.24%-19.56M | -39.87%-81.17M | -17.65M | -19.61M | -164.27%-58.03M | -21.96M |
| Net income continuous Operations | 0.24%-19.56M | -39.87%-81.17M | ---17.65M | ---19.61M | -164.27%-58.03M | ---21.96M |
| Minority interest income | ||||||
| Net income attributable to the parent company | 0.24%-19.56M | -39.87%-81.17M | -17.65M | -19.61M | -164.27%-58.03M | -21.96M |
| Preferred stock dividends | ||||||
| Other preferred stock dividends | ||||||
| Net income attributable to common stockholders | 0.24%-19.56M | -39.87%-81.17M | -17.65M | -19.61M | -164.27%-58.03M | -21.96M |
| Basic earnings per share | 0.42%-2.44 | -631.85%-53.08 | -2.2058 | -2.4502 | -164.27%-7.2528 | -2.7444 |
| Diluted earnings per share | 0.42%-2.44 | -631.85%-53.08 | -2.2058 | -2.4502 | -164.27%-7.2528 | -2.7444 |
| Dividend per share | ||||||
| Currency Unit | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg